SHARE:   Share to Facebook Share to Twitter Share to Linked In Share via Email  

Back To Search Results

C178 - Biomarkers in Dementia

Event Time: Wednesday April 26, 2017 3:30 pm to 5:30 pm
Topic(s): Aging, Dementia, Cognitive, and Behavioral Neurology
Director(s): Beau Ances MD, PhD, MS, FAAN
Description: Knowledge in the area of dementia continues to rapidly change. Faculty will present an overview of Alzheimer's disease; frontotemporal dementia ; vascular dementia; and rapidly progressive dementia. Biomarkers that have been developed to assess these dementias will be discussed- including clinical, neuropsychological, neuroimaging, and cerebrospinal fluid measures. Dementia management also will be reviewed. This program complements C153: Alzheimer's Dementia: Diagnosis and Treatment, but covers independent topics.
Completion Message: After completing this course participants should gain an understanding of the differential diagnosis of dementia (e.g. Alzheimer's disease vs. Frontotemporal dementia vs. Vascular dementia vs. Rapidly progressive dementia), potential role for neuropsychology, neuroimaging, and molecular biomarkers in supporting a particular diagnosis, and the management of dementing illnesses.
CME Credits: 2
Core Competencies: Patient Care, Medical Knowledge

Program Speakers - Tentative

Start/End Time Title Faculty
3:30 PM - 3:35 PM Introduction Beau Ances MD, PhD, MS, FAAN 
3:35 PM - 4:00 PM Biomarkers in Alzheimer's Disease Beau Ances MD, PhD, MS, FAAN 
4:00 PM - 4:30 PM Biomarkers in Frontotemporal Dementia and Dementia with Lewy Body Murray Grossman MD, FAAN 
4:30 PM - 5:00 PM Biomarkers in Rapidly Progressive Dementia Gregory Day MD, MSc 
5:00 PM - 5:20 PM Biomarkers in Vascular Dementia Rebecca Gottesman MD 
5:20 PM - 5:30 PM Questions and Answers Faculty 


Speaker Disclosure
Beau M. Ances, MD, PhD, MS, FAAN Dr. Ances has nothing to disclose.

Gregory S. Day, MD, MSc Dr. Day has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with DynaMed (EBSCO Health) and MedEdicus.. Dr. Day holds stock and/or stock options in ANI Pharmaceuticals (a generic pharmaceutical company).. Dr. Day has received research support from Avid Radiopharmaceuticals (a wholly-owned subsidiary of Eli Lilly)..

Rebecca F. Gottesman, MD Dr. Gottesman has received personal compensation in an editorial capacity for the Journal Neurology.

Murray Grossman, MD, FAAN Dr. Grossman has received personal compensation for activities with Avid. Dr. Grossman has received personal compensation in an editorial capacity for Neurology. Dr. Grossman has received research support from BMS.

Register Now

Related Courses

Saturday April 21, 2018

7:00 AM-9:00 AM
C1 Mild Cognitive Impairment: Implications for Clinicians Ronald Petersen PhD, MD, FAAN
9:30 AM-11:30 AM
C13 Neuroimaging Biomarkers Across the Dementia Spectrum Liana Apostolova MD, FAAN
C10 More than Medicine: How to Access Home Care, Support Caregivers, and Discuss Complex Situations in Advanced Neurologic Disease Farrah Daly MD, MBA
1:30 PM-3:30 PM
C19 The Neurology of Social Behavior Bradford Dickerson MD

Sunday April 22, 2018

7:00 AM-9:00 AM
C32 Clinicopathological Correlation Session in Dementia David Irwin MD

Monday April 23, 2018

7:00 AM-9:00 AM
C66 Cognitive Impairment due to Alzheimer's Disease: Using Old Skills and New Tools for Diagnosis and Treatment David Knopman MD, FAAN
1:00 PM-3:00 PM
C77 Present and Future Biomarkers in Dementia: A Case-based Approach Jonathan Graff-Radford MD
3:30 PM-5:30 PM
C91 Chronic Traumatic Encephalopathy: Update Andrew Budson MD

Tuesday April 24, 2018

7:00 AM-9:00 AM
C97 Vascular Cognitive Impairment and Dementia: Current Status and Future Larry Goldstein MD, FAAN, FAHA
1:00 PM-3:00 PM
N3 Neuroscience in the Clinic: Challenges in Genetic Diagnosis in Neurology Guy Rouleau MD, PhD,
Massimo Pandolfo MD, FAAN
C106 Assessment and Management of Neuropsychiatric Symptoms in Neurocognitive Disorders Daniel Kaufer MD, FAAN
C109 Neurologic Complications in Adults with Down Syndrome Andrea Gropman MD
3:30 PM-5:30 PM
C130 Disorders of Motor Programming: The Apraxias and Action-Intentional Disorders Chalk Talk Kenneth Heilman MD, FAAN

Wednesday April 25, 2018

7:00 AM-9:00 AM
C135 Neurocognitive Assessment for Neurologists Mario Mendez MD, PhD, FAAN
C133 Higher Cortical Visual Disorders: Case-based Review Sashank Prasad MD
9:15 AM-11:30 AM
PL5 Frontiers in Neuroscience Plenary Session
1:00 PM-3:00 PM
C145 Severe TBI: From ICU to Rehabilitation Susanne Muehlschlegel MD,MPH
C146 Non-Alzheimer's Dementia I: Frontotemporal Dementias Gil Rabinovici MD
3:30 PM-5:30 PM
C161 Non-Alzheimer's Dementia II: Lewy Body Dementias and Other Parkinsonian Dementias Gil Rabinovici MD

Friday April 27, 2018

7:00 AM-9:00 AM
C219 The Early-Onset Dementias Mario Mendez MD, PhD, FAAN
1:00 PM-3:00 PM
C227 Behavioral Neurology: A Case-based Approach A. Barrett MD, FAAN
3:30 PM-5:30 PM
C238 Memory Disorders: A Case-based Approach David Wolk MD


Forgot Password?